FDA Warning Letter — SkinnyRX

Case 717989 — FEI 3040745670

The FDA took a Warning Letter action against SkinnyRX on Feb 20, 2026 (Sacramento, CA). The action was issued by CDER and concerns drugs products.

Action details

Facility
SkinnyRX
Date
Feb 20, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Sacramento, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.